BSE filing, NSE: MISHKA. Summary written from the filing by ALFA Finder's alert engine.
Mishka Exim Ltd: key numbers
- Share price
- ₹41.00
- Market cap
- ₹59.24 Cr
- Revenue (annual)
- ₹22.35 Cr
- Net profit (annual)
- ₹1.98 Cr
- P/E (TTM)
- 30.3×Sector 49.5×
- Promoter holding
- 58.96%+0.31% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mishka Exim Ltd
All →Mishka Exim Other Announcement
Mishka Exim Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI LODR regulations.
Mishka Exim Management Change
Mishka Exim Ltd announced the appointment of Mr. Rakesh Aggarwal as a Non-Executive Independent Director, as approved by members at the AGM held on September 30, 2026.
Mishka Exim Other Announcement
Mishka Exim Limited announced the reappointment of M/s Gaur & Associates as Statutory Auditors, effective from the conclusion of the 12th AGM for a five-year term.
Mishka Exim Annual General Meeting
Mishka Exim Limited held its 12th Annual General Meeting on September 30, 2026, to transact ordinary and special business. The company reported the proceedings of the meeting.
Mishka Exim Other Announcement
Mishka Exim Limited has approved the reappointment of M/s Gaur & Associates as Statutory Auditors for a five-year term, subject to shareholder approval at the AGM.
Mishka Exim Annual Report
Mishka Exim Ltd submitted its Annual Report for the financial year 2025-26. The 12th Annual General Meeting is scheduled for September 30, 2026.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.